MedPath

Effect of coenzyme Q10 supplementation on ulcerative colitis

Phase 3
Recruiting
Conditions
lcerative colitis.
Ulcerative colitis
Registration Number
IRCT20090822002365N17
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

The willingness to voluntarily participate in the study
The definitive diagnosis of ulcerative colitis by using histological studies of mucosal colon, rectum, and jejunium biopsy by the physician in the mild to moderate phase,
The consumer of only one of the drug groups 5 -Amino salicylic acid (Pentasa, Mesalazine or Asacol), as well as azathioprine
An age 18 and above
BMI greater than 18.5 and less than 30
Each of the two sexes

Exclusion Criteria

Changing the type and dosage of the drug over the past month
The incidence of other autoimmune diseases, cancer
Pregnancy or lactation in women
The use of multi vitamin-mineral supplements, antioxidants, and also the use of anticoagulants, blood cholesterol lowering drugs, anti-TNF drugs, and glucocorticosteroids over the past month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath